Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2015

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2015

Enanta Pharma (ENTA) Misses Q3 EPS by 6c

August 6, 2015 5:09 PM EDT

Enanta Pharma (NASDAQ: ENTA) reported Q3 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

... More